Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 2,550 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Attention Deficit and Disruptive Behavior Disorders
Interventions: Parent-Educator Action Response (PEAR), Daily Report Card; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: Not listed
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Autistic Disorder, Asperger's Disorder, Pervasive Developmental Disorder NOS
Interventions: D-cycloserine, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 5 Years to 11 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Indianapolis, Indiana • Cincinnati, Ohio

Conditions: ADHD
Interventions: methylphenidate HCl (Concerta), Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 297 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Overweight and Obesity, Attention-Deficit Hyperactivity Disorder
Interventions: PBT-EF; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 8 Years to 12 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: PF-03654746, Placebo capsules; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 7
States / cities: Lafayette, California • Los Alamitos, California • Newport Beach, California + 4 more

Conditions: Fetal Alcohol Spectrum Disorders, Attention Deficit Hyperactivity Disorder
Interventions: Trigeminal Nerve Stimulation (TNS); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 8 Years to 12 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Child Development, Child Behavior Disorders, Reactive Attachment Disorder
Interventions: Promoting First Relationships Program, Early Education Support Program; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 10 Months to 24 Months
Enrollment: 236 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Autism Spectrum Disorder
Interventions: Transcranial Magnetic Stimulation (TMS); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: AKL-T01, AKL-T09; Device
Lead sponsor: Akili Interactive Labs, Inc.; Industry
Eligibility: 8 Years to 12 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 20
States / cities: Dothan, Alabama • Scottsdale, Arizona • Newport Beach, California + 17 more

Conditions: Attention-Deficit/Hyperactivity Disorder
Interventions: Neurofeedback treatment; Device
Lead sponsor: Ohio State University; Other
Eligibility: 7 Years to 10 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: Asheville, North Carolina • Columbus, Ohio

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: DC-Stimulator (PLUS version); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Developmental Delay
Interventions: CHICA DevScreen Module; Other
Lead sponsor: Indiana University; Other
Eligibility: 1 Day to 3 Years
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: TBI, Attention Deficits, Motor Impairments
Interventions: GVS, Sham GVS, Armeo Spring; Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Naltrexone, Methylphenidate Abuse
Interventions: Placebo, Methylphenidate 60 mg, Treatment Phase Sequence 4213, Treatment Phase Sequence 2134, Treatment Phase Sequence 1342, Treatment Phase Sequence 3421; Drug
Lead sponsor: Avekshan LLC; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: ADHD
Interventions: Behavioral tools integrated within mehealth for ADHD software; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Years to 5 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Autism
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: Evdokia Anagnostou; Individual
Eligibility: 18 Years to 60 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Attention Deficit Disorder With Hyperactivity, Amphetamine-Related Disorders, Substance-Related Disorders
Interventions: NRP104; Drug
Lead sponsor: New River Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Adult Participants
Interventions: Centanafadine; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Occupational Therapy Intervention for Women with ADHD; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 21 Years to 55 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Attention Deficit Hyperactivity Disorder, Insomnia
Interventions: atomoxetine, placebo; Drug
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Infant, Newborn, Infant, Small for Gestational Age, Infant, Extremely Low Birth Weight
Interventions: Donor Milk, Preterm Formula; Biological · Dietary Supplement
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 21 Days
Enrollment: 483 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • Atlanta, Georgia + 13 more

Conditions: Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Centanafadine SR, Placebo; Drug · Other
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 590 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: ADHD
Interventions: Neurofeedback, Cognitive training; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 7 Years to 11 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autism Spectrum Disorders
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Months to 18 Years
Enrollment: 389 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Parent-Educator Action Response

D-Cycloserine and Social Skills Training in Autism Spectrum Disorders

A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder

Families, Responsibility, Education, Support, and Health for Executive Function

A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Promoting Infant Mental Health in Foster Care

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Software Treatment for Actively Reducing Severity of ADHD

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

An Study of Transcranial Direct Current Stimulation in Adults With ADHD

The CHICA Developmental Screening Study

Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors

Study for Naltrexone on the Abuse Potential of Methylphenidate

Preschool ADHD On-line Behavioral Treatment

Intranasal Oxytocin in the Treatment of Autism

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects

Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD

The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants

A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)

Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder